Patent · US Active

Attenuated influenza viruses and vaccines

US11549101B2 · kind B2 · utility

0Cited by

8References

11Claims

0Family size

Assignee

The Research Foundation for The State University of New York · US

Inventors

Steffen Mueller · Pforzheim, DE
Eckard Wimmer · Port Jefferson, US
Bruce Futcher · Stony Brook, US
Steven Skiena · Albany, US
Chen Yang · Elmont, US

Key dates

Filing date	Jun 10, 2019
Grant date	Jan 10, 2023
Priority date	—
Expiry date	Sep 28, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2760/16162
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention provides highly attenuated influenza viruses and vaccines. The attenuated viruses and vaccines proliferate well and have high safety factors. The attenuated viruses providing protective immunity from challenge by virus of the same subtype, as well as cross protection against heterologous viruses.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.